Literature DB >> 11180201

Mitochondrial dysfunction and neuromuscular disease.

R A Nardin1, D R Johns.   

Abstract

Mitochondrial diseases are a heterogeneous group of disorders with widely varying clinical features, due to defects in mitochondrial function. Involvement of both muscle and nerve is common in mitochondrial disease. In some cases, this involvement is subclinical or a minor part of a multisystem disorder, but myopathy and neuropathy are a major, often presenting, feature of a number of mitochondrial syndromes. In addition, mitochondrial dysfunction may play a role in a number of classic neuromuscular diseases. This article reviews the role of mitochondrial dysfunction in neuromuscular disease and discusses a rational approach to diagnosis and treatment of patients presenting with a neuromuscular syndrome due to mitochondrial disease.

Entities:  

Mesh:

Year:  2001        PMID: 11180201     DOI: 10.1002/1097-4598(200102)24:2<170::aid-mus30>3.0.co;2-0

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  21 in total

1.  Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals.

Authors:  Enzo Nisoli; Sestina Falcone; Cristina Tonello; Valeria Cozzi; Letizia Palomba; Mara Fiorani; Addolorata Pisconti; Silvia Brunelli; Annalisa Cardile; Maura Francolini; Orazio Cantoni; Michele O Carruba; Salvador Moncada; Emilio Clementi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-15       Impact factor: 11.205

Review 2.  Bimodal targeting of microsomal cytochrome P450s to mitochondria: implications in drug metabolism and toxicity.

Authors:  Michelle C Sangar; Seema Bansal; Narayan G Avadhani
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-10       Impact factor: 4.481

3.  Basal Ganglia calcification in mitochondrial disorders.

Authors:  Josef Finsterer; Wolfgang Kopsa
Journal:  Metab Brain Dis       Date:  2005-09       Impact factor: 3.584

4.  A case of mitochondrial cardiomyopathy with pericardial effusion evaluated by (99m)Tc-MIBI myocardial scintigraphy.

Authors:  Noriyuki Yajima; Yoshikazu Yazaki; Kunihiro Yoshida; Kenji Sano; Wataru Takahashi; Yasuyuki Sasaki; Uichi Ikeda
Journal:  J Nucl Cardiol       Date:  2009 Nov-Dec       Impact factor: 5.952

5.  Investigation of tRNA(Leu/Lys) and ATPase 6 genes mutations in Huntington's disease.

Authors:  Sadaf Kasraie; Massoud Houshmand; Mohammad Mehdi Banoei; Solmaz Etemad Ahari; Mehdi Shafa Shariat Panahi; Parvin Shariati; Mohammad Bahar; Mostafa Moin
Journal:  Cell Mol Neurobiol       Date:  2008-04-02       Impact factor: 5.046

6.  Role of carnitine in disease.

Authors:  Judith L Flanagan; Peter A Simmons; Joseph Vehige; Mark Dp Willcox; Qian Garrett
Journal:  Nutr Metab (Lond)       Date:  2010-04-16       Impact factor: 4.169

7.  Reproducibility of the lactate stress test.

Authors:  Josef Finsterer
Journal:  Metab Brain Dis       Date:  2003-06       Impact factor: 3.584

Review 8.  Nitric oxide in myogenesis and therapeutic muscle repair.

Authors:  Clara De Palma; Emilio Clementi
Journal:  Mol Neurobiol       Date:  2012-07-22       Impact factor: 5.590

Review 9.  Differential diagnosis of idiopathic inflammatory myopathies.

Authors:  Alan N Baer
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.686

10.  Progress in understanding mitochondrial disorders.

Authors:  Anuradha Ganesh; Govindaswamy Kumaramanickavel
Journal:  Middle East Afr J Ophthalmol       Date:  2008-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.